Abstract:NANOG is an important stem cell transcription factor involved in human development and cancerogenesis. Its expression is complex and regulated on different levels. Moreover, NANOG protein might regulate hundreds of target genes at the same time. NANOG is crucial for preimplantation development phase and progressively decreases during embryonic stem cells differentiation, thus regulating embryonic and fetal development. Postnatally, NANOG is undetectable or expressed in very low amounts in the majority of human tissues. NANOG re-expression can be detected during cancerogenesis, already in precancerous lesions, with increasing levels of NANOG in high grade dysplasia. NANOG is believed to enable cancer cells to obtain stem-cell like properties, which are believed to be the source of expanding growth, tumor maintenance, metastasis formation, and tumor relapse. High NANOG expression in cancer is frequently associated with advanced stage, poor differentiation, worse overall survival, and resistance to treatment, and is therefore a promising prognostic and predictive marker. We summarize the current knowledge on the role of NANOG in cancerogenesis and development, including our own experience. We provide a critical overview of NANOG as a prognostic and diagnostic factor, including problems regarding its regulation and detection. Impact statement NANOG has emerged as a key stem cell transcription factor in normal development and cancerogenesis. It is generally regarded as a good prognostic and predictive factor in various human cancers. It is less known that it is expressed already at precancerous stages in various organs, suggesting that finally an ideal candidate diagnostic marker has been discovered, enabling to distinguish between true dysplasia and reactive atypia. NANOG regulation is complex, and new insights into our understanding of its regulation might provide important information for future development in a broad field of two entirely different processes, i.e. normal development and cancerogenesis, showing how a physiologic mechanism can be used and abused, transforming itself into a key mechanism of disease development and progression.

NANOGP8 is a retrogene expressed in cancers.

Nanog1 in Ntera-2 and Recombinant Nanogp8 from Somatic Cancer Cells Adopt Multiple Protein Conformations and Migrate at Multiple M.W Species

The human pluripotency gene NANOG/NANOGP8 is expressed in gastric cancer and associated with tumor development

Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade.

Regulation of NANOG in cancer cells

Overexpression of Nanog Protein is Associated with Poor Prognosis in Gastric Adenocarcinoma

NANOG expression in human development and cancerogenesis

Nanog in human tumors and stem cells

Roles of NANOGP8 in cancer metastasis and cancer stem cell invasion during development of castration-resistant prostate cancer

The Pluripotency Factor Nanog Promotes Breast Cancer Tumorigenesis and Metastasis

Pluripotential competence of cells associated with Nanog activity

The Roles of NANOG in Tumorigenesis

Pluripotency Factor Nanog is Tumorigenic by Deregulating DNA Damage Response in Somatic Cells

RNA interference-mediated silencing of NANOG leads to reduced proliferation and self-renewal, cell cycle arrest and apoptosis in T-cell acute lymphoblastic leukemia cells via the p53 signaling pathway

Expression of NANOG in Human Gliomas and Its Relationship with Undifferentiated Glioma Cells

Insights into the Nanog gene: A propeller for stemness in primitive stem cells

Nanog, A Novel Prognostic Marker for Lung Cancer

Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human

Malignant Transformation of 293 Cells Induced by Ectopic Expression of Human Nanog

Cloning and Characterization of a Nanog Pseudogene in Sika Deer (Cervus nippon)

NANOGP1, a tandem duplicate of NANOG, exhibits partial functional conservation in human naïve pluripotent stem cells